Order Article Reprints

Ragusa F, Ferrari SM, Elia G, Paparo SR, Balestri E, Botrini C, Patrizio A, Mazzi V, Guglielmi G, Foddis R, et al. Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer. International Journal of Molecular Sciences. 2022; 23(10):5731. https://doi.org/10.3390/ijms23105731

Ragusa, Francesca, Silvia Martina Ferrari, Giusy Elia, Sabrina Rosaria Paparo, Eugenia Balestri, Chiara Botrini, Armando Patrizio, Valeria Mazzi, Giovanni Guglielmi, Rudy Foddis, and et al. 2022. "Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer" International Journal of Molecular Sciences 23, no. 10: 5731. https://doi.org/10.3390/ijms23105731

Ragusa, F., Ferrari, S. M., Elia, G., Paparo, S. R., Balestri, E., Botrini, C., Patrizio, A., Mazzi, V., Guglielmi, G., Foddis, R., Spinelli, C., Ulisse, S., Antonelli, A., & Fallahi, P. (2022). Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer. International Journal of Molecular Sciences, 23(10), 5731. https://doi.org/10.3390/ijms23105731